Neutral
QRG Capital Management Inc. increased its stake in Edwards Lifesciences Corporation (NYSE:EW) by 50.1% during the fourth quarter, acquiring an additio...
Edwards Lifesciences announced 10-year results from its COMMENCE aortic trial, highlighting the long-term durability and sustained performance of its ...
Neutral
Kornitzer Capital Management Inc. KS trimmed its position in shares of Edwards Lifesciences Corporation (NYSE:EW – Free Report) by 18.4% during the 4t...
Neutral
Caisse Des Depots ET Consignations reduced its stake in Edwards Lifesciences Corporation by 19.4%, selling 12,427 shares. Despite this, other institut...
Bullish
Barclays has raised its price target for Edwards Lifesciences Corporation (NYSE:EW) to $110 from $104, maintaining an Overweight rating, following str...
Neutral
Edwards Lifesciences Corporation (NYSE:EW) has received an average "Moderate Buy" recommendation from 28 brokerages, with an average 12-month price ta...
Neutral
AMG National Trust Bank acquired a new stake in Edwards Lifesciences Corporation (NYSE:EW – Free Report) during the fourth quarter, according to its m...
Edwards Lifesciences (EW) reported strong first-quarter 2026 earnings per share of 78 cents, beating the consensus estimate of 73 cents. The company a...
Bullish
Edwards Lifesciences reported strong Q1 2026 financial results, surpassing analyst expectations with adjusted EPS of $0.78 and revenue of $1.65 billio...
Neutral
Birch Hill Investment Advisors LLC has reduced its stake in Edwards Lifesciences Corporation by 1.8%, selling 13,385 shares, and now holds 743,680 sha...